Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...

UPS today announced fourth-quarter 2024 consolidated revenues of $25.3 billion, a 1.5% increase from the fourth quarter of ...

SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced that on ...

Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, is pleased to invite investors to a webinar on February 5 ...

The annual reporting season for calendar year-end companies is in full swing and public companies should consider several new ...

This Client Alert provides an overview of new developments and highlights key considerations for calendar year-end public ...

Good afternoon and welcome to the NVE Corporation Conference Call for the Quarter Ended December 31, 2024. I’m Dan Baker, NVE ...